Pharmacopeia ( will assist WHO’s Special Program for Research and Training in Tropical Diseases (WHO/TDR) in its efforts to develop antimalarial agents.
The company will receive funding to conduct research on compounds identified through WHO/TDR’s drug-screening program involving a network of centers in developed and developing countries. The goal of this project is to identify new lead series with the potential to become novel malaria drug candidates.

Next articleUMMZ Periodical Cicada Page